Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006421

Chief Legal Officer acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Keane Raymond T · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 1 in the form +22,500 24,124 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 2 in the form Stock Option (Right to Buy) +45,000 45,000 D
Loading xslF345X03/doc4.xml…